These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8910536)

  • 1. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production.
    Kimble RB; Srivastava S; Ross FP; Matayoshi A; Pacifici R
    J Biol Chem; 1996 Nov; 271(46):28890-7. PubMed ID: 8910536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.
    Kitazawa R; Kimble RB; Vannice JL; Kung VT; Pacifici R
    J Clin Invest; 1994 Dec; 94(6):2397-406. PubMed ID: 7989596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual modulation of osteoclast differentiation by lipopolysaccharide.
    Zou W; Bar-Shavit Z
    J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice.
    Kimble RB; Bain S; Pacifici R
    J Bone Miner Res; 1997 Jun; 12(6):935-41. PubMed ID: 9169353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression.
    Shevde NK; Bendixen AC; Dienger KM; Pike JW
    Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7829-34. PubMed ID: 10869427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage colony-stimulating factor pretreatment of bone marrow progenitor cells regulates osteoclast differentiation based upon the stage of myeloid development.
    Yang X; Pande S; Scott C; Friesel R
    J Cell Biochem; 2019 Aug; 120(8):12450-12460. PubMed ID: 30805994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-alpha, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells.
    Fujikawa Y; Sabokbar A; Neale SD; Itonaga I; Torisu T; Athanasou NA
    Bone; 2001 Mar; 28(3):261-7. PubMed ID: 11248655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro investigation of the roles of the proinflammatory cytokines tumor necrosis factor-α and interleukin-1 in murine osteoclastogenesis.
    Jules J; Feng X
    Methods Mol Biol; 2014; 1155():109-23. PubMed ID: 24788177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.
    Cenci S; Weitzmann MN; Roggia C; Namba N; Novack D; Woodring J; Pacifici R
    J Clin Invest; 2000 Nov; 106(10):1229-37. PubMed ID: 11086024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
    J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
    Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
    J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation.
    Atkins GJ; Haynes DR; Geary SM; Loric M; Crotti TN; Findlay DM
    Bone; 2000 Jun; 26(6):653-61. PubMed ID: 10831938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss.
    Lee SK; Kalinowski JF; Jacquin C; Adams DJ; Gronowicz G; Lorenzo JA
    J Bone Miner Res; 2006 May; 21(5):695-702. PubMed ID: 16734384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclastic potential of human CFU-GM: biphasic effect of GM-CSF.
    Hodge JM; Kirkland MA; Aitken CJ; Waugh CM; Myers DE; Lopez CM; Adams BE; Nicholson GC
    J Bone Miner Res; 2004 Feb; 19(2):190-9. PubMed ID: 14969388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period.
    Kimble RB; Matayoshi AB; Vannice JL; Kung VT; Williams C; Pacifici R
    Endocrinology; 1995 Jul; 136(7):3054-61. PubMed ID: 7789332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1.
    Srivastava S; Weitzmann MN; Kimble RB; Rizzo M; Zahner M; Milbrandt J; Ross FP; Pacifici R
    J Clin Invest; 1998 Nov; 102(10):1850-9. PubMed ID: 9819371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
    Kobayashi K; Takahashi N; Jimi E; Udagawa N; Takami M; Kotake S; Nakagawa N; Kinosaki M; Yamaguchi K; Shima N; Yasuda H; Morinaga T; Higashio K; Martin TJ; Suda T
    J Exp Med; 2000 Jan; 191(2):275-86. PubMed ID: 10637272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-alpha.
    Ma T; Miyanishi K; Suen A; Epstein NJ; Tomita T; Smith RL; Goodman SB
    Cytokine; 2004 May; 26(3):138-44. PubMed ID: 15135808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.